Q

uniQure NV
D

QURE

14.770
USD
-0.23
(-1.53%)
مغلق
حجم التداول
28,916
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
808,347,330
أصول ذات صلة
B
BLUE
-0.15000
(-3.69%)
3.91000 USD
C
CLLS
-0.01900
(-1.18%)
1.59100 USD
C
CRSP
0.520
(1.38%)
38.220 USD
E
EDIT
0.01500
(0.93%)
1.63000 USD
F
FATE
0.09000
(7.38%)
1.31000 USD
N
NTLA
0.20000
(2.32%)
8.83000 USD
R
RCKT
0.16000
(2.04%)
8.02000 USD
S
SGMO
-0.01210
(-1.63%)
0.72800 USD
V
VYGR
0.10000
(2.82%)
3.64000 USD
المزيد
الأخبار المقالات

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.